CRSP : Insider Transactions for Crispr Therapeutics Ag

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

New Search

Get Insiders for :

Crispr Therapeutics Ag (CRSP)

$55.24

0.49 (0.88%) as of 4:30 Fri 5/24

Download

Exchange:

N/A

Security Type:

N/A

Shares Out:

70,650,000

Market Cap:

3.90(B)

Last Volume:

Avg Vol:

52 Week Range:

$38.62 - $89.12

Level I Sector:

N/A

Level II Sector:

N/A

Level III Sector:

N/A

Member Indexes:

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : -

Guru Rank Value : -

Guru Occurances : -


6 Months 1 Year 2 Year

Company Profile CRISPR Therapeutics is a gene editing company focused on the development of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) based therapeutics. CRISPR/Cas9 is a technology for gene editing, the process of altering specific sequences of genomic DNA. Co. is developing several gene-edited allogeneic cell therapy programs. Co.'s main product candidate, CTX001, is an investigational ex vivo CRISPR gene-edited therapy that is being evaluated for patients suffering from transfusion-dependent beta thalassemia or severe sickle cell disease in which a patient's hematopoietic stem cells are engineered to produce fetal hemoglobin in red blood cells.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	0	0	0
Total Buy Value	$0	$0	$0	$0
Total People Bought	0	0	0	0
Total Buy Transactions	0	0	0	0
Total Shares Sold	61,438	159,721	184,721	409,721
Total Sell Value	$4,291,798	$10,834,513	$12,456,407	$25,314,056
Total People Sold	3	3	3	3
Total Sell Transactions	7	12	13	22
End Date	2024-02-25	2023-11-24	2023-05-26	2022-05-26

Adjust Filter Settings

Records found: 483

Page 15 of 20

Filer's Name

Relation Title

Off-Dir-10%

Tran. Date

Form

Action

Price

Mkt Value

D/I

Shares

Holdings

Rank

3m +/-

Form

Bolzon Bradley J Phd

Director

– • –

2017-09-05

$0.00

I/I

(2,614,157)

Bolzon Bradley J Phd

Director

– • –

2017-09-05

$0.00

I/I

311,052

1,240

Novak Rodger

Chief Executive Officer

• • –

2017-09-05

$20.33

$78,320

D/D

(3,853)

1,148,007

Novak Rodger

Chief Executive Officer

• • –

2017-09-05

$1.81

$6,974

D/D

3,853

1,151,860

Novak Rodger

Chief Executive Officer

• • –

2017-08-31

$20.87

$305,073

D/D

(14,617)

1,148,007

Novak Rodger

Chief Executive Officer

• • –

2017-08-30

$20.31

$1,179,950

D/D

(58,103)

1,162,624

Novak Rodger

Chief Executive Officer

• • –

2017-08-30

$1.81

$10,357

D/D

5,722

1,220,727

Kulkarni Samarth

Chief Business Officer

• – –

2017-08-30

$20.00

$80,000

D/D

(4,000)

106,893

Novak Rodger

Chief Executive Officer

• • –

2017-08-28

$20.06

$354,919

D/D

(17,692)

1,215,005

Novak Rodger

Chief Executive Officer

• • –

2017-08-28

$1.81

$32,023

D/D

17,692

1,232,697

Kulkarni Samarth

Chief Business Officer

• – –

2017-08-28

$20.09

$465,162

D/D

(23,154)

110,893

Emster Kurt Von

Director

– • –

2017-08-28

$19.79

$1,741,738

I/I

(88,011)

1,951,359

Emster Kurt Von

Director

– • –

2017-08-25

$19.52

$291,102

I/I

(14,913)

2,039,370

Emster Kurt Von

Director

– • –

2017-08-24

$19.23

$151,302

I/I

(7,868)

2,054,283

Emster Kurt Von

Director

– • –

2017-08-23

$18.53

$130,359

I/I

(7,035)

2,062,151

Emster Kurt Von

Director

– • –

2017-08-22

$18.53

$202,978

I/I

(10,954)

2,069,186

Emster Kurt Von

Director

– • –

2017-08-21

$18.51

$23,138

I/I

(1,250)

2,080,140

Emster Kurt Von

Director

– • –

2017-08-18

$18.53

$35,207

I/I

(1,900)

2,081,390

Emster Kurt Von

Director

– • –

2017-08-17

$18.74

$254,733

I/I

(13,593)

2,083,290

Emster Kurt Von

Director

– • –

2017-08-16

$19.27

$395,960

I/I

(20,548)

2,096,883

Emster Kurt Von

Director

– • –

2017-08-15

$19.53

$499,695

I/I

(25,586)

2,117,431

Emster Kurt Von

Director

– • –

2017-08-14

$19.64

$588,866

I/I

(29,983)

2,143,017

Emster Kurt Von

Director

– • –

2017-08-08

$18.71

$371,394

I/I

(19,850)

2,190,872

Dylan-Hyde Tyler

Chief Legal Officer

• – –

2017-08-08

$18.60

$24,422

D/D

(1,313)

153,204

Emster Kurt Von

Director

– • –

2017-08-07

$18.53

$289,494

I/I

(15,623)

2,210,722

483 Records found	Previous 10 11 12 13 14 15 16 17 18 19 Next	Page 15 of 20

Transaction Code Key:				Ownership Code Key
B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
OE	- Options Exercised	A	- Acquired
IO	- Initital Ownership	D	- Disposed

Summary:

Chart:

3m +/-: